Dr. Beatrice Ranieri

Silvercatpharma project aims at developing C-C cross-coupling reactions catalysed by d11-blocks metals, particularly silver,
for the synthesis of pharmaceuticals in Novartis. It strives to have an impact in terms of cost, environment and international
visibility because of the use of silver as an alternative catalyst. The project offers me a great opportunity to obtain further
training, such as clusters preparation, computational and flow chemistry, and to define my final career in academia or
industry because of the possibility of working in these two different environments.

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 658256